SCHEMBL19080396

SCHEMBL19080396

c1ccc2c(c1)ccc1c2sc2cc(-c3ccc(-c4c5ccccc5c(-c5ccc6oc7ccccc7c6c5)c5ccccc45)cc3)c3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
CYP1A1 P04798 5/20 0.33
KDM4E B2RXH2 4/20 0.33
CYP1B1 Q16678 4/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 3/20 0.33
HPGD P15428 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
CYP1A2 P05177 3/20 0.33
MEN1 O00255 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19077538 0.86 MEN1 (0.33) MAPTKDM4EKMT2AALDH1A1RAB9A
SCHEMBL19080397 0.85 NPC1 (0.34) MAPTKDM4EKMT2AALDH1A1RAB9A
SCHEMBL24518919 0.85 KDM4E (0.35) MAPTCYP1A1KDM4ECYP1B1KMT2A
SCHEMBL17247187 0.85 KDM4E (0.37) MAPTCYP1A1KDM4ECYP1B1KMT2A
SCHEMBL17247148 0.85 KDM4E (0.37) MAPTCYP1A1KDM4ECYP1B1KMT2A
SCHEMBL19080287 0.85 CYP1A1 (0.38) CYP1A1CYP1B1ALDH1A1HPGDCYP1A2
SCHEMBL19080223 0.84 CYP1A1 (0.46) MAPTCYP1A1KDM4ECYP1B1KMT2A
SCHEMBL19082407 0.84 KDM4E (0.35) MAPTCYP1A1KDM4ECYP1B1KMT2A
SCHEMBL19080392 0.83 TDP1 (0.36) MAPTCYP1A1KDM4EKMT2AALDH1A1
SCHEMBL19076887 0.83 MAPT (0.35) MAPTKDM4EKMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 MAPT 1538/4885CYP1A1 147/4885KDM4E 3545/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 MAPT 1538/4885CYP1A1 147/4885KDM4E 3545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.